Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
A Phase III Study of Immediate Versus Delayed Chemotherapy for Asymptomatic Advanced Colorectal Cancer
Sponsor: NCIC Clinical Trials Group
Listed as NCT00002570, this PHASE3 trial focuses on Colorectal Cancer and remains completed. Sponsored by NCIC Clinical Trials Group, it has been updated 8 times since 1994, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
May 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Apr 2020 — May 2020 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2020 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jul 1994
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NCIC Clinical Trials Group
- North Central Cancer Treatment Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ann Arbor, United States, Bismarck, United States, Cedar Rapids, United States, Des Moines, United States, Duluth, United States, Fargo, United States, Grand Forks, United States, New Orleans, United States, Peoria, United States, Rapid City, United States and 6 more location s